Member Info for iceman888

Oh, well. Will wait for 1p to top up.

This will take time.

oh

Looks like we will have a great week!

Remember news can come anytime before Friday!

Morning RB,

How are you feeling today? I see Mr 50K is back

MM asking for premium on any amount!

4MM @ 19p

1MM @19.5

Bought 1.5 million more...... I have too many buy this delay has to be positive.

So I can BUY BUY BUY MORE!!!

The delay is POSITIVE!!!

I want to buy more on this dip!

Eyes wide open!

My bet is Sunday newspapers!

Cant wait for Monday!

Excalibur Medicines Limited, a subsidiary of Excalibur Healthcare Services Ltd., announced that the clinical team will report on the ARCADIA trial in September.

Excalibur Medicines Ltd (“EML”) has secured exclusive rights to and owns the patents on a drug, AZD1656, which is being developed as a potential therapeutic for people with diabetes suffering from COVID-19. The ARCADIA trial which took place across 31 sites was completed in July this year.

The research project was arranged and structured by Professor Sir Chris Evans, Chairman and CEO of Excalibur Healthcare Services, through its subsidiary, Excalibur Medicines Ltd. Sir Chris worked closely with Professor John Martin and his team at St George Street, a UK-based biomedical research charity, which secured the initial project and permission to run the trial from AstraZeneca.

The aim of the ARCADIA trial is to determine whether AZD1656 improves clinical outcomes in diabetic patients hospitalised with COVID-19. The World Health Organisation’s (WHO) 8-point Ordinal Scale for Clinical Improvement will be used as the standard methodology for measuring patient outcomes. As at date of publication, 156 patients have been recruited and have completed treatment. The data is now being assessed and it is the intention of EML to seek a sale of the drug, a license or partnership deal as soon as possible after the data is published.

FULLY LOCKED AND LOADED!

NO PAIN, NO GAIN!

Holding these has been painful.... now time for GAINS!

GLA!

Bought few more today in the morning! All trades ending with 201/401 ( Approx +80,000). lol

Still strongly believe that Suzy will come good. Hopefully, my luck will change soon.

Holding strong. Its been VERY VERY VERY painful last few weeks. But not selling was the right thing to do. I didn't buy much below 70p as all my other stocks were also down. Happy for anyone who bought in below 70p.

GLA!

Wow! How can RB/OB not see this!

we also have a 9.

1+9 = 10... this is also 1!

So we have double confirmation!

We are due half year report. These are the previous dates: When Suzy took over she issued the half year report early. I expecting it next week.

07/09/2020 Half year report

26/09/2019 Half year report

25/09/2018 Half year report

26/09/2017 Half year report

We should get more details including an update on progress of VAL201. Don't forget Suzy is holding a presentation end of this month!! Without a decent update no questions.... Expect big news coming soon! And an EXCITING live Q&A.

All trades ending with 201 are buys!

What if VAL is bought out within next 3 months. What happens to Cenkos warrants? LOL!

Picked up few million !

Cant believe i got a chance to buy here!

All buys!

loving it!!

Why take on a new director if the drug has failed?

Looks like this is a sure JACKPOT!

HOLD ON TO YOUR SHARES!

PM2022!

EXCELLENT POST!

Like I have said Cenkos have a lotter ticket with the winning numbers. They will be silly to waste this! Nothing to lose and everything to gain.

Hi Porky9,

I would have to strongly disagree that she is about to do a placing. She knows that the shareholder will not be happy with placing at current price. Suzy even mentioned this in her recent email to me. Maybe there is a placing in the future but not right now!

My thinking is that she is happy for the broker to make some good money on Valirx provided that they help her get funding for VAL401. She hold 45% of VAL401 and she doesn't make any money when VAL shoots up. VAL401 has been stuck for few years.

I'm looking forward to reading what Adam has to say. I wouldn't worry about a placing below 22p. I just don't see that happening!